Patent ID: 11911381
Assignee: SUMITOMO PHARMA CO. LTD.
Field: Pharmaceuticals (Chemistry)
Classification: CPC A  C | IPC A  C

Claim 14:
15. The compound of claim 13, wherein the crystal form is characterized by a powder x-ray diffraction pattern having diffraction angle (2θ°) peaks of 4.9°±0.2°, 8.1°±0.2°, 8.6°±0.2°, 9.8°±0.2°, 13.9°±0.2°, 14.5°±0.2°, 17.2°±0.2°, 17.8°±0.2°, 18.4°±0.2°, 19.0°±0.2°, and 20.5°±0.2°.